Recent press releases

The share issue in I-Tech AB (publ) for listing on First North was over-subscribed

I-Tech AB (publ) ("I-Tech" or "the Company") has completed the share issue to public and institutional investors in Sweden to subscribe for 1 875 000 shares in the Company of approximately SEK 38.5 Million ("Offering"). The interest in participating in the share issue has been strong and overall, the share issue was subscribed to approximately…

Read more

I-Tech AB carries out a share issue of MSEK 44.1 ahead of listing on Nasdaq First North

The Board of I-Tech AB ("I-Tech" or "The Company") has decided to carry out an equity issue of up to 2 150 000 shares and apply for listing of the Company's shares on Nasdaq First North. 

Read more

I-Tech AB signs deal for largest ever Selektope® order with Chugoku Marine Paints

I-Tech AB, the Swedish developer of the bio-repellent antifouling ingredient Selektope®, has signed a significant supply agreement with one of the industry’s leading paint manufacturers representing the largest ever single order of the technology to-date. This deal represents yet another significant milestone for Selektope®, confirming the central position of coatings containing the ingredient in the…

Read more

I-Tech AB strengthens Selektope® supply chain with strategic acquisition

Swedish bio-technology company I-Tech AB has today announced the strategic acquisition of manufacturing process technology and IP, for the production of medetomidine, from Cambrex Corporation (NYSE: CBM). The transaction consolidates the supply chain and improves I-Tech’s industrial capabilities. I-Tech AB has registered and patented medetomidine as a marine antifouling agent and is offering the active…

Read more

Subscribe to receive our press releases




I-Tech Social Media Hub


Follow I-Tech on Twitter

Fancy an interesting read? Our May e-newsletter is hot off the press! Click the link to open in your web browser: https://t.co/SOpKfw78wz #selektope

Load More...

Follow I-Tech on LinkedIn